MAOB and Parkinson disease: In contrast to early reports demonstrating the potentiation of 6-OHDA-induced brain DA depletion by administration of the irreversible MAO (B) inhibitor pargyline [76], convincing evidence exists that MAO inhibitors exhibit protective effects in this PD model.